1. [Clinical problems in medical mycology: Problem number 51].
- Author
-
Romero M, Messina F, Marín E, Arechavala A, Negroni R, Depardo R, Walker L, Benchetrit A, and Santiso G
- Subjects
- Antifungal Agents therapeutic use, Antigens, Fungal blood, Cryptococcosis drug therapy, Cryptococcosis microbiology, Cryptococcosis pathology, Cryptococcus gattii immunology, Female, Fluconazole therapeutic use, Fungemia drug therapy, Fungemia microbiology, Fungemia pathology, Humans, Lung Diseases, Fungal drug therapy, Lung Diseases, Fungal microbiology, Lung Diseases, Fungal pathology, Middle Aged, Cryptococcosis diagnosis, Cryptococcus gattii isolation & purification, Cysts microbiology, Fungemia diagnosis, Lung Diseases, Fungal diagnosis, Thyroid Diseases microbiology
- Abstract
A 48 year-old immunocompetent woman, who had a nodular lesion in the neck and a dense infiltrate at the lower lobe of the left lung, presented at the Mycology Unit of Muñiz Hospital of Buenos Aires City. The pulmonary infiltrate disappeared spontaneously 3 months later. The histopathological study of the nodular lesion showed capsulated yeasts (mucicarmin and alcian blue positive stains) compatible with Cryptococcus. The mycological study of a new sample, obtained by a nodular puncture, allowed the isolation of yeasts, identified as Cryptococcus gattii (VGII). Latex test for Cryptococcus capsular antigen in serum was positive (1/100). CSF cultures rendered negative results. Fluconazole at a daily dose of 800mg was given during 45 days with partial improvement; as cultures from a new clinical sample were positive for Cryptococcus, the antimycotic was changed to itraconazole 400mg/day for 5 months, with an excellent clinical response., (Copyright © 2017 Asociación Española de Micología. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF